Article
Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model
13 Nov 2019
Abstract excerpt
Sepsis remains a major public health problem with no major therapeutic advances over the last several decades. The clinical and biological heterogeneity of sepsis have limited success of potential new therapies. Accordingly, there is considerable interest in developing a precision medicine approach to inform more rational development, testing, and targeting of new therapies. We previously developed the Pediatric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
